Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

Published: November 2012
No. of Pages: 187
   

Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

Summary

GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates”. An essential source of information and analysis on the Polish healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts. In 2011, the UAE population was 8.4 million which was mainly due to the increasing number of immigration in the country. In 2011, the pharmaceutical market was estimated at $1.9 billion and is expected to reach $3.7 billion by 2020 at a projected CAGR of 7%. The medical device market was worth approximately $670.7m in 2011 and is expected to reach $979m by 2020 at a projected CAGR of 4%.


The positive trends in United Arab Emirates healthcare market can be attributed primarily to -
- Multiple health-care facilities
- Liberal trade policies
- Medical tourism

Scope

- An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are Julphar, Neopharma, GlaxoSmithKline, Pfizer, and Novartis, and the key players covered for the medical device market are F. Hoffmann-La Roche Ltd, Siemens Healthcare, Medtronic, Boston Scientific Corporation Inc and Abbott Laboratories.
- Insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices
- Detailed analysis of United Arab Emirates political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the healthcare market in United Arab Emirates.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnerships
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market

Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 Report Guidance 10
3 Overview of the Pharmaceutical and Medical Device Markets 11
3.1 Pharmaceutical Market 11
3.1.1 Market Overview 11
3.1.2 Supply Channels 13
3.1.3 Market Segments 15
3.1.4 Over-the-Counter Drugs 17
3.1.5 Major Therapeutic Areas 18
3.1.6 Major Players 21
3.2 Medical Device Market 45
3.2.1 Market Overview 45
3.2.2 Overview of the Top Five Segments 48
3.2.3 Major Players 59
3.3 Market Drivers and Barriers 79
3.3.1 Drivers 79
3.3.2 Barriers 80
4 Market Access 82
4.1 Reimbursement and Payer Landscape 82
4.1.1 Healthcare System Overview 82
4.1.2 Reimbursement Process 82
4.1.3 Overview of Insurance Providers 85
4.1.4 Patient Share in Healthcare Spending 86
4.1.5 Price Trends in Healthcare Services 88
4.1.6 Pricing Policies 89
4.2 Regulatory Landscape 90
4.2.1 Overview of Regulatory Agencies 90
4.2.2 New Drug Approval Process 93
4.2.3 Marketing Authorization Procedure for Generic Pharmaceutical Products 94
4.2.4 Medical Device Approval Process 96
4.2.5 Licensing Process for Pharmaceutical and Medical Device Manufacturing 97
4.2.6 Licensing Process for Pharmaceutical Exports and Imports 98
4.2.7 Intellectual Property Rights 98
4.2.8 Clinical Trial Regulations 103
4.2.9 Pharmaceutical Advertising Regulations 105
4.2.10 Pharmacy Regulations 105
4.2.11 Labeling and Packaging Regulations 106
5 Country Analysis 108
5.1 Political Environment 108
5.1.1 Political Structure 108
5.1.2 Analysis of the Current Political Environment 109
5.1.3 Healthcare Policy Initiatives 110
5.2 Economic Landscape 111
5.3 Economic Indicators 113
5.3.1 Gross Domestic Product 113
5.3.2 Gross National Income 118
5.3.3 Inflation 119
5.3.4 Currency Exchange Rate 123
5.3.5 Foreign Direct Investment 124
5.3.6 Foreign Exchange Reserves 125
5.3.7 Trade Balance 126
5.3.8 Government Net Debt 128
5.3.9 Major Industries 130
5.4 Demography 131
5.4.1 Population 131
5.4.2 Education and Literacy 148
5.4.3 Employment 150
5.4.4 Disease Burden 152
5.5 Healthcare Infrastructure 154
5.5.1 Healthcare Facilities 154
5.5.2 Healthcare Parameters 162
5.5.3 Environmental Health 164
5.5.4 Healthcare Personnel 167
5.6 Healthcare Expenditure 170
5.6.1 Overview 170
5.6.2 Major Components of Healthcare Spending 171
5.6.3 Share of Public and Private Sectors 172
5.7 Trade Associations 173
5.7.1 Arab Union of Producers of Drugs and Medical Supplies 173
5.7.2 Emirates Medical Association 173
5.7.3 Pharmaceutical Research and Manufacturers Association Gulf 173
5.7.4 Gulf Pharmaceutical Industries Association 173
5.7.5 Middle East Medical Devices and Diagnostics Trade Association 173
5.7.6 Middle East Generic Association 173
5.8 Trade Fairs 174
6 Opportunities and Challenges 175
6.1 Opportunities 175
6.2 Challenges 176
7 Appendix 178
7.1 Abbreviations 178
7.2 Bibliography 179
7.3 Methodology 185
7.3.1 Coverage 185
7.3.2 Secondary Research 185
7.3.3 Forecasting 186
7.3.4 Primary Research 186
7.3.5 Expert Panel Validation 186
7.4 Contact Us 186
7.5 Disclaimer 187

1.1 List of Tables
Table 1: Pharmaceutical Market, UAE, Revenue ($bn), 2006-2011 12
Table 2: Pharmaceutical Market, UAE, Revenue ($bn), Forecast, 2012-2020 13
Table 3: Distribution Channel, Pharmaceutical Mark-ups (%), UAE, 2011 14
Table 4: Drugs Going Off-patent, Revenues ($bn), Global, 2011-2014 16
Table 5: Major Products, GlaxoSmithKline, Global, Revenue ($m), 2011 28
Table 6: Late-stage Pipeline, GlaxoSmithKline, 2012 28
Table 7: Major Products, Pfizer, Global, Revenue ($m), 2011 33
Table 8: Late-stage Pipeline, Pfizer, 2012 34
Table 9: Major Products, Novartis, Global, Revenue ($m), 2012 39
Table 10: Planned Filings, Novartis, 2012 =2016 39
Table 11: Medical Device Market, UAE, Revenue ($m), 2006-2011 46
Table 12: Medical Device Market, UAE, Revenue ($m), 2012-2020 47
Table 13: Medical Device Market, UAE, Segments, Revenue ($m), 2011 48
Table 14: Cardiovascular Devices Market, UAE, Revenue ($m), 2006-2011 49
Table 15: Sales Trends for Major Players*, Cardiovascular Devices, UAE, 2010 50
Table 16: In Vitro Diagnostics Market, UAE, Revenue ($m), 2006-2011 51
Table 17: Sales Trends for Major Players*, In Vitro Diagnostics Devices, UAE, 2010 52
Table 18: Orthopedic Devices Market, UAE, Revenue ($m), 2006-2011 53
Table 19: Sales Trends for Major Players*, Orthopedic Devices, UAE, 2010 54
Table 20: Ophthalmic Devices Market, UAE, Revenue ($m), 2006-2011 55
Table 21: Sales Trends for Major Players*, Ophthalmic Devices, UAE, 2010 56
Table 22: Drug Delivery Devices Market, UAE, Revenue ($m), 2006-2011 57
Table 23: Sales Trends for Major Players*, Drug Delivery Devices, UAE, 2010 58
Table 24: Major Medical Device Companies, UAE, Revenue ($m), 2010 59
Table 25: Major Products, Roche, Global Revenues ($m), 2012 60
Table 26: Late-stage Pipeline, Roche, 2012 61
Table 27: Major Products, Siemens Healthcare, Revenue ($m), 2012 64
Table 28: Late-stage Pipeline, Siemens Healthcare, 2012 64
Table 29: Major Products, Medtronic, Global, Revenue ($m), 2011 68
Table 30: Major Products, Boston Scientific, Global, Revenue ($m), 2010 72
Table 31: Healthcare Spending, UAE, Patient''s Share (%), 2005-2010 87
Table 32: Price Trends in the Healthcare Sector (%), UAE, 2008-2012 88
Table 33: GDP Per Capita ($), UAE, 2006-2011 114
Table 34: GDP Per Capita ($), UAE, Forecast, 2012-2020 115
Table 35: GDP, UAE, Annual Growth (%), 2006-2011 116
Table 36: GDP, UAE, Annual Growth (%), Forecast, 2012-2020 117
Table 37: GNI Per Capita ($), UAE, 2005-2010 118
Table 38: Average Consumer Price Index, UAE, 2006-2011 119
Table 39: Average Consumer Price Index, UAE, Forecast, 2012-2020 120
Table 40: Average Consumer Price, UAE, Annual Change (%), 2006-2011 121
Table 41: Average Consumer Price, UAE, Annual Change (%), Forecast, 2012-2020 122
Table 42: Currency Exchange Rate (AED/$), UAE, 2006-2011 123
Table 43: Foreign Direct Investment ($bn), UAE, 2005-2010 124
Table 44: Foreign Exchange Reserves ($bn), UAE, 2005-2010 125
Table 45: Imports of Goods and Services ($bn), UAE, 2005-2010 127
Table 46: Exports of Goods and Services ($bn), UAE, 2005-2010 127
Table 47: Government Debt ($bn), UAE, 2006-2011 128
Table 48: Government Debt ($bn), UAE, Forecast, 2012-2020 129
Table 49: Major Industries , the UAE, Production ($bn), 2010 130
Table 50: Population (million), UAE, 2006-2011 132
Table 51: Population (million), UAE, Forecast, 2012-2020 133
Table 52: Urban and Rural Population, UAE, Share (%), 2006-2011 134
Table 53: Urban and Rural Population, UAE, Share (%) Forecast, 2012-2020 135
Table 54: Age Groups, UAE, Population Distribution (%), 2006-2011 136
Table 55: Age Groups, UAE, Population Distribution (%), Forecast, 2012-2020 137
Table 56: Births (Per 1,000 Population), UAE, 2005-2010 138
Table 57: Mortality (Per 1,000 Population), UAE, 2005-2010 139
Table 58: Major Causes of Mortality (Registered Deaths), UAE, 2010 140
Table 59: Children <5 Years Age, UAE, Mortality (Per 1,000 Live Births), 2005-2010 141
Table 60: Maternal Mortality (Per 100,000 Live Births), UAE, 2005-2010 142
Table 61: Immunization Rate (%), UAE, 2005-2010 143
Table 62: Major Causes of Male Mortality (Registered Deaths), UAE, 2010 144
Table 63: Major Causes of Mortality, Females (Registered Deaths), UAE, 2010 145
Table 64: Gender Ratio (M/F), UAE, 2005-2010 147
Table 65: Life Expectancy at Birth (Years), UAE, 2005-2010 147
Table 66: Levels of Higher Education, UAE, Student Enrolment, 2010 149
Table 67: Graduate Education, UAE, Students Enrolment, 2005-2010 149
Table 68: Unemployment Rate (%), UAE, 2005-2010 151
Table 69: Employees (‘000s), UAE, 2009 151
Table 70: Major Diseases, UAE, 2010 152
Table 71: Major Diseases, UAE, DALYs (Per 100,000 Population), 2004 153
Table 72: Number of Hospitals, UAE, 2005-2010 155
Table 73: Public and Private Hospitals, UAE, 2005-2010 156
Table 74: Hospitals by Standard of Care, UAE, Share (%), 2008 157
Table 75: Beds by Specialty, UAE, 2008 158
Table 76: Urban and Rural Healthcare Facilities, Share (%), UAE, 2005-2010 159
Table 77: Diagnostic Facilities by Ownership, UAE, 2008 160
Table 78: Diagnostic Equipment by Ownership, UAE, 2008 161
Table 79: Hospital Beds, (Per 10,000 Population), UAE, 2005-2010 162
Table 80: Physicians (Per 10,000 Population), UAE, 2005-2010 163
Table 81: Deaths Attributable to the Environment (Per 100,000 Population), UAE, 2004 164
Table 82: PM10 (µm/m3), UAE, 2005-2010 165
Table 83: CO2 Emissions (Million Tons), UAE, 2005-2010 167
Table 84: Healthcare Personnel (Per 10,000 Population), UAE, 2005-2010 168
Table 85: Healthcare Personnel by Specialty, UAE, 2008 169
Table 86: Healthcare Expenditure (% of GDP), UAE, 2005-2010 170
Table 87: Major Component of Healthcare Spending, UAE, Share (%), 2009 171
Table 88: Healthcare Expenditure, UAE, Public-Private Share (%), 2005-2010 172
Table 89: Major Healthcare Trade Fairs, UAE, 2012-2013 174

1.2 List of Figures
Figure 1: Pharmaceutical Market, UAE, Revenue ($bn), 2006-2011 12
Figure 2: Pharmaceutical Market, UAE, Revenue ($bn), Forecast, 2012-2020 13
Figure 3: Distribution Channels, UAE, 2012 14
Figure 4: Medical Device Market, UAE, Revenue ($m), 2006-2011 46
Figure 5: Medical Device Market ($m), UAE, Revenue ($m), Forecast, 2012-2020 47
Figure 6: Medical Device Market, UAE, Segments, Revenue ($m), 2011 48
Figure 7: Cardiovascular Devices Market, UAE, Revenue ($m), 2006-2011 49
Figure 8: Sales Trends for Major Players*, Cardiovascular Devices, UAE, 2006-2010 50
Figure 9: In Vitro Diagnostics Market, UAE, Revenue ($m), 2006-2011 51
Figure 10: Sales Trends for Major Players*, In Vitro Diagnostics Devices, UAE, 2006-2010 52
Figure 11: Orthopedic Devices Market, UAE, Revenue ($m), 2006-2011 53
Figure 12: Sales Trends for Major Players*, Orthopedic Devices, UAE, 2006-2010 54
Figure 13: Ophthalmic Devices Market, UAE, Revenue ($m), 2006-2011 55
Figure 14: Sales Trends for Major Players*, Ophthalmic Devices, UAE, 2006-2010 56
Figure 15: Drug Delivery Devices Market, UAE, Revenue ($m), 2006-2011 57
Figure 16: Sales Trends for Major Players*, Drug Delivery Devices, UAE, 2006-2010 58
Figure 17: Major Medical Device Companies, UAE, Revenue ($m), 2010 59
Figure 18: Drivers and Barriers, Healthcare Market, UAE, 2012 81
Figure 19: Healthcare Overview, UAE, 2012 85
Figure 20: Healthcare Spending, UAE, Patient Share (%), 2005-2010 87
Figure 21: Price Trends in the Healthcare Sector (%), UAE, 2008-2012 88
Figure 22: Ministry of Health, Organization Structure, UAE, 2012 92
Figure 23: Health Authority - Abu Dhabi, Organization Structure, UAE, 2012 93
Figure 24: New Drug Approval Process, UAE, 2012 95
Figure 25: Patent Approval Process, UAE, 2012 100
Figure 26: Trademark Approval Process, UAE, 2012 102
Figure 27: Clinical Trial Regulation Process, UAE, 2012 104
Figure 28: GDP Per Capita ($), UAE, 2006-2011 114
Figure 29: GDP Per Capita ($), UAE, Forecast, 2012-2020 115
Figure 30: GDP, UAE, Annual Growth (%), 2006-2011 116
Figure 31: GDP, UAE, Annual Growth (%), Forecast, 2012-2020 117
Figure 32: GNI Per Capita ($), UAE, 2005-2010 118
Figure 33: Average Consumer Price Index, UAE, 2006-2011 119
Figure 34: Average Consumer Price Index, UAE, Forecast, 2012-2020 120
Figure 35: Average Consumer Price, UAE, Annual Change (%), 2006-2011 121
Figure 36: Average Consumer Price, UAE, Annual Change (%), Forecast, 2012-2020 122
Figure 37: Currency Exchange Rate (AED/$), UAE, 2006-2011 123
Figure 38: Foreign Direct Investment ($bn), UAE, 2005-2010 124
Figure 39: Foreign Exchange Reserves ($bn), UAE, 2005-2010 125
Figure 40: Imports of Goods and Services ($bn), UAE, 2005-2010 126
Figure 41: Exports of Goods and Services ($bn), UAE, 2005-2010 127
Figure 42: Government Debt ($bn), UAE, 2006-2011 128
Figure 43: Government Debt ($bn), UAE, Forecast, 2012-2020 129
Figure 44: Major Industries, UAE, Production ($bn), 2010 130
Figure 45: Population (million), UAE, 2006-2011 132
Figure 46: Population (million), UAE, Forecast, 2012-2020 133
Figure 47: Urban and Rural Population, UAE, Share (%), 2006-2011 134
Figure 48: Urban and Rural Population, UAE, Share (%) Forecast, 2012-2020 135
Figure 49: Age Groups, UAE, Population Distribution (%), 2006-2011 136
Figure 50: Age Groups, UAE, Population Distribution (%), Forecast, 2012-2020 137
Figure 51: Births (Per 1,000 Population), UAE, 2005-2010 138
Figure 52: Mortality (Per 1,000 Population), UAE, 2005-2010 139
Figure 53: Major Causes of Mortality (Registered Deaths), UAE, 2010 140
Figure 54: Children <5 Years Age, UAE, Mortality (Per 1,000 Live Births), 2005-2010 141
Figure 55: Maternal Mortality (Per 100,000 Live Births), UAE, 2005-2010 142
Figure 56: Immunization Rate (%), UAE, 2005-2010 143
Figure 57: Major Causes of Male Mortality (Registered Deaths), UAE, 2010 144
Figure 58: Major Causes of Mortality, Females (Registered Deaths), UAE, 2010 145
Figure 59: Gender Ratio (M/F), UAE, 2005-2010 146
Figure 60: Life Expectancy at Birth (Years), UAE, 2005-2010 147
Figure 61: Levels of Higher Education, UAE, Student Enrolment, 2010 148
Figure 62: Graduate Education, UAE, Student Enrolment, 2005-2010 149
Figure 63: Unemployment Rate (%), UAE, 2005-2010 150
Figure 64: Employees (‘000s), UAE, 2009 151
Figure 65: Major Diseases, UAE, 2010 152
Figure 66: Major Diseases, UAE, DALYs (Per 100,000 Population), 2004 153
Figure 67: Number of Hospitals, UAE, 2005-2010 155
Figure 68: Public and Private Hospitals, UAE, 2005-2010 156
Figure 69: Hospitals by Standard of Care, UAE, Share (%), 2008 157
Figure 70: Beds by Specialty, UAE, 2008 158
Figure 71: Urban and Rural Healthcare Facilities, Share (%), UAE, 2005-2010 159
Figure 72: Diagnostic Facilities by Ownership, UAE, 2008 160
Figure 73: Diagnostic Equipment by Ownership, UAE, 2008 161
Figure 74: Hospital Beds, (Per 10,000 Population), UAE, 2005-2010 162
Figure 75: Physicians (Per 10,000 Population), UAE, 2005-2010 163
Figure 76: Deaths Attributable to the Environment (Per 100,000 Population), UAE, 2004 164
Figure 77: PM10 (µm/m3), UAE, 2005-2010 165
Figure 78: CO2 Emissions (Million Tons), UAE, 2005-2010 166
Figure 79: Healthcare Personnel (Per 10,000 Population), UAE, 2005-2010 168
Figure 80: Healthcare Personnel by Specialty, UAE, 2008 169
Figure 81: Healthcare Expenditure (% of GDP), UAE, 2005-2010 170
Figure 82: Major Components of Healthcare Spending, UAE, Share (%), 2009 171
Figure 83: Healthcare Expenditure, UAE, Public-Private Share (%), 2005-2010 172
Figure 84: Opportunities and Challenges, Healthcare Market, UAE, 2012 177

Published By: GlobalData
Product Code: GlobalData26530


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100